SCHEMBL18784233

SCHEMBL18784233

COc1ccccc1S(=O)(=O)Cc1ccc(-c2ccoc2)c(OCCN)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 3/20 0.41
ALDH1A1 P00352 5/20 0.38
TP53 P04637 3/20 0.38
MAPT P10636 3/20 0.38
MAPK1 P28482 3/20 0.38
LMNA P02545 4/20 0.37
HTT P42858 2/20 0.37
CSNK2A1 P68400 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
USP2 O75604 3/20 0.36
TSHR P16473 3/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
CYP1A2 P05177 2/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2D6 P10635 2/20 0.36
ALOX15 P16050 2/20 0.36
CYP2C19 P33261 2/20 0.36
CLK4 Q9HAZ1 1/20 0.36
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18784242 0.85 CSNK2A1 (0.40) TP53MAPTMAPK1LMNACSNK2A1
SCHEMBL18784223 0.80 CSNK2A1 (0.39) TP53MAPTMAPK1LMNACSNK2A1
SCHEMBL18784228 0.78 CSNK2A1 (0.41) CSNK2A1CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL1648897 0.78 METAP2 (0.41) BRD4ALDH1A1TP53MAPTLMNA
Hydrochloric Acid SCHEMBL1649195 0.77 METAP2 (0.41) BRD4ALDH1A1TP53MAPTLMNA
SCHEMBL18784246 0.74 HTR7 (0.43) ALDH1A1CSNK2A1SMN1; SMN2KDM4E
SCHEMBL18784252 0.74 KDM4E (0.41) ALDH1A1LMNAHTTCSNK2A1GAA
SCHEMBL18784214 0.72 CSNK2A1 (0.36) MAPTCSNK2A1MEN1KMT2ACYP1A2
SCHEMBL1647710 0.69 METAP2 (0.50) BRD4ALDH1A1TP53MAPTLMNA
SCHEMBL3573637 0.69 CSNK2A1 (0.55) ALDH1A1MAPTLMNACSNK2A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2486004-B1 SULPHONE COMPOUNDS FOR USE IN THE TREATMENT OF OBESITY ZAFGEN INC (US) 2017-05-03 EP claimed